Medical Sciences Program and Guangdong-Technion Israel Institute of Technology

As part of the launching of the new Guangdong-Technion Israel Institute of Technology (GTIIT) in the City of Shantou in the Guangdong Province of China, and in cooperation with the neighboring Shantou University, a Medical Sciences Program has been established. Within the framework of this program, we have established a collaboration between researchers from the two Institutes, Shantou University and the Technion, with emphasis on cancer research. As a part of this plan (led by the Deans of the Faculties of Medicine of both Universities), opportunities to launch collaborative research by investigators from the two universities were discussed, resulting in a call for proposals in both campuses.

Total of 12 applications were submitted, and reviewed independently by committees in both campuses. An ad hoc committee that was overseen by the Deans in both institutes have then discussed and ranked the applications for funding. The following proposals were funded for 3 years, pending annual review and satisfactory progress:

  1. Dr. Aaron Ciechanover (Technion) and Dr. Guo-Jun Zhang (Shantou University) for their work titled: “Identification of the Ubiquitin Ligase for Notch 3 Intracellular Domain: Implications for Tumor Suppression and Drug Development”.
  2. Dr. Ze’ev Ronai (Technion) and Dr. Hao Zhang (Shantou University) for their work titled: “Defining the Sharpin/PTPRO/PRMT5 regulatory axis in melanoma and esophageal cancers”.
  3. Dr. Israel Vlodavsky (Technion) and Dr. Xiaojun Yang (Shantou University) for their work titled: “The heparanase-CD24-L1CAM axis in glioma tumorigenesis “.
  4. Dr. Dorit Ben-Shachar (Technion) and Dr. Haiyun Xu (Shantou University) for their work titled: “The interplay between mitochondrial dysfunction dopaminergic hyperactivity and hypomyelination in the brain: implications for schizophrenia”.
  5. Dr. Gera Neufeld (Technion) and Dr. Enmin-Li (Shantou University) for their work titled: “The role of non-secreted, enzymatically inactive isoforms of LOXL2 in tumor progression”.
  6. Dr. Stavit Allon-Shalev (Technion) and Dr. Min Su (Shantou University) for their work titled: “The association of common Genetic variants among populations of the “Esophageal cancer belt of Asia” and Squamous Esophageal Carcinoma”.